Zosano Pharma Corp (NASDAQ:ZSAN) shares skyrocketed over 170% in the past three days, after the company reported positive pivotal trial data for its M207 migraine …
Roth Capital analyst Scott Henry is out today with a research note on shares of Catalyst Pharmaceuticals Inc (NASDAQ:CPRX), following recent meeting with the company’s senior management. …
Tonix Pharmaceuticals Holding Corp. (NASDAQ:TNXP) has been left to discontinue its program for fibromyalgia-treating pipeline drug Tonmya in the wake of phase 3 …
Roth Capital analyst Scott Henry weighed in today with his views on BioDelivery Sciences International, Inc.(NASDAQ:BDSI), after the company announced a supply constraint for its opioid dependence product …
On August 19, China Cord Blood Corporation (NYSE:CO), China’s top umbilical cord blood storage services provider, released its preliminary unaudited financial results for …
In a research report released today, Roth Capital analyst Scott Henry maintained a Buy rating on Catalyst Pharmaceuticals Inc (NASDAQ:CPRX) with a $7.00, which …
Roth Capital analyst Scott Henry came out yesterday with a research report on CorMedix Inc. (NYSEMKT:CRMD), maintaining a Neutral rating, while reducing the price …
In a research report published Friday, Roth Capital analyst Scott Henry reiterated a Buy rating on shares of Titan Pharmaceuticals, Inc. (OTCMKTS:TTNP), while raising the …
Roth Capital analyst Scott Henry came out with a favorable report on Titan Pharmaceuticals, Inc. (OTCMKTS:TTNP), maintaining a Buy rating on the stock with a …
Roth Capital’s healthcare analyst Scott Henry weighed in on IGI Laboratories, Inc. (NYSE:IG), maintainig a Neutral rating and reducing the price target to $7.
